Andrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, Mona O Mohsen, Martin F Bachmann, Tal I Arnon
{"title":"Regulation of pulmonary plasma cell responses during secondary infection with influenza virus.","authors":"Andrew J MacLean, Joao P P L Bonifacio, Sophia L Oram, Mona O Mohsen, Martin F Bachmann, Tal I Arnon","doi":"10.1084/jem.20232014","DOIUrl":null,"url":null,"abstract":"<p><p>During secondary infection with influenza virus, plasma cells (PCs) develop within the lung, providing a local source of antibodies. However, the site and mechanisms that regulate this process are poorly defined. Here, we show that while circulating memory B cells entered the lung during rechallenge and were activated within inducible bronchus-associated lymphoid tissues (iBALTs), resident memory B (BRM) cells responded earlier, and their activation occurred in a different niche: directly near infected alveoli. This process required NK cells but was largely independent of CD4 and CD8 T cells. Innate stimuli induced by virus-like particles containing ssRNA triggered BRM cell differentiation in the absence of cognate antigen, suggesting a low threshold of activation. In contrast, expansion of PCs in iBALTs took longer to develop and was critically dependent on CD4 T cells. Our work demonstrates that spatially distinct mechanisms evolved to support pulmonary secondary PC responses, and it reveals a specialized function for BRM cells as guardians of the alveoli.</p>","PeriodicalId":15760,"journal":{"name":"Journal of Experimental Medicine","volume":"221 7","pages":""},"PeriodicalIF":12.6000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11044945/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Experimental Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1084/jem.20232014","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/4/25 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
During secondary infection with influenza virus, plasma cells (PCs) develop within the lung, providing a local source of antibodies. However, the site and mechanisms that regulate this process are poorly defined. Here, we show that while circulating memory B cells entered the lung during rechallenge and were activated within inducible bronchus-associated lymphoid tissues (iBALTs), resident memory B (BRM) cells responded earlier, and their activation occurred in a different niche: directly near infected alveoli. This process required NK cells but was largely independent of CD4 and CD8 T cells. Innate stimuli induced by virus-like particles containing ssRNA triggered BRM cell differentiation in the absence of cognate antigen, suggesting a low threshold of activation. In contrast, expansion of PCs in iBALTs took longer to develop and was critically dependent on CD4 T cells. Our work demonstrates that spatially distinct mechanisms evolved to support pulmonary secondary PC responses, and it reveals a specialized function for BRM cells as guardians of the alveoli.
在继发感染流感病毒期间,肺部会出现浆细胞(PC),从而提供局部抗体来源。然而,调控这一过程的部位和机制尚不明确。在这里,我们发现循环记忆 B 细胞在再感染期间进入肺部,并在诱导性支气管相关淋巴组织(iBALTs)中被激活,而常驻记忆 B 细胞(BRM)则更早地做出反应,而且它们的激活发生在不同的位置:直接靠近受感染的肺泡。这一过程需要 NK 细胞,但在很大程度上与 CD4 和 CD8 T 细胞无关。由含有 ssRNA 的病毒样颗粒诱导的先天性刺激可在没有同源抗原的情况下触发 BRM 细胞分化,这表明激活的阈值很低。相比之下,iBALTs 中 PC 的扩增需要更长的时间,而且主要依赖于 CD4 T 细胞。我们的研究表明,支持肺继发性 PC 反应的机制在空间上是不同的,它揭示了 BRM 细胞作为肺泡守护者的特殊功能。
期刊介绍:
Since its establishment in 1896, the Journal of Experimental Medicine (JEM) has steadfastly pursued the publication of enduring and exceptional studies in medical biology. In an era where numerous publishing groups are introducing specialized journals, we recognize the importance of offering a distinguished platform for studies that seamlessly integrate various disciplines within the pathogenesis field.
Our unique editorial system, driven by a commitment to exceptional author service, involves two collaborative groups of editors: professional editors with robust scientific backgrounds and full-time practicing scientists. Each paper undergoes evaluation by at least one editor from both groups before external review. Weekly editorial meetings facilitate comprehensive discussions on papers, incorporating external referee comments, and ensure swift decisions without unnecessary demands for extensive revisions.
Encompassing human studies and diverse in vivo experimental models of human disease, our focus within medical biology spans genetics, inflammation, immunity, infectious disease, cancer, vascular biology, metabolic disorders, neuroscience, and stem cell biology. We eagerly welcome reports ranging from atomic-level analyses to clinical interventions that unveil new mechanistic insights.